Kymera Therapeutics

5 followers


Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Industries

Employees

51-200

Links

Org chart

Hiring!

Nello Mainolfi
Co-Founder, President & CEO

Nello Mainolfi

Collapse
Jared Gollob
Chief Medical Officer
Ellen Chiniara
Chief Legal Officer & Corporate Secretary
Brian Albarran
SVP, Corporate Strategy
Kevin Dushney
SVP, IT & Operations
Vijay Sabesan
SVP, Technical Operations
Karen Weisbach
VP, People & Culture
Jolly Bhatia
VP, Quality
Aimee Mishkin
VP, Regulatory Affairs
Melissa Brody
VP, Business Development
Juliet Williams
Head of Research
Arsalan S. Qazi M.D.
Vice President, Head Of Immunology And Inflammation Clinical Development

Board & advisors

Bruce Booth
Co-Founder & Chairman
Jeff Albers
Director
Leigh Morgan
Director
Steven A. Carr
Scientific Advisor
Jean-Laurent Casanova
Scientific Advisor
David Frank
Scientific Advisor
Nick Keen
Scientific Advisor
Owen O’Connor
Scientific Advisor
Antonio Sica
Scientific Advisor
David Spiegel
Scientific Advisor
Robert Terkeltaub
Scientific Advisor